EOLS

Evolus, Inc.

NasdaqAdd to watchlist

Healthcare · Drug Manufacturers—Specialty & Generic

$8.39

+$0.04+0.48%

Delayed · 2026-08-21T20:00:00.000Z · marketstack

Aug 11, 2026$8.39

+$0.05+0.60%over 1M

Day range63% of range

$8.24$8.48

Session

Previous close: $8.35
Open: $8.35
Volume: 579.89K
Avg volume: -
Day high: $8.48
Day low: $8.24

Fundamentals

Visualize fundamentals and more

Market cap: 553.15M
P/E ratio: -
EPS (TTM): -$0.52
Dividend yield: -
Beta: 1.48
Shares outstanding: 65.93M

Source SEC EDGAR · 9/10/2026

Risk factors, year on year

Item 1AMarch 2026 10-KMarch 2025as filed.

added: 37
dropped: 36
re-drafted: 60

Out of 225 passages in this year’s Item 1A.

New this year

We have incurred significant losses since our inception, and we may continue to incur losses, which could adversely affect the market price of our common stock and our ability to raise additional capital.

72 more passages, included withBespoke

Recent activity

15 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like Evolus, Inc.

Also filed under Drug Manufacturers, ranked by how closely they sit beside EOLS.

LLYELI LILLY & Co
JNJJOHNSON & JOHNSON
AMGNAMGEN INC
MRKMerck & Co., Inc.
ABBVAbbVie Inc.
PFEPFIZER INC

Ask about Evolus, Inc.

The assistant answers from what EOLS has actually filed: 9 annual reports filed with the SEC, 17 Form 4 filings from the last year and 3 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from EOLS's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding Evolus, Inc., and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with Evolus, Inc.

Separate the decisions from the paperwork
Every Form 4 EOLS insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about Evolus, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.